Steris (STE) Stock Forecast & Price Target

Compare

429 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

STE Analyst Ratings

Moderate Buy

1 Buy

1 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Steris

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

STE Stock 12 Month Forecast

Average Price Target

$285.00

▲(8.05% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Steris in the last 3 months. The average price target is $285.00 with a high forecast of $285.00 and a low forecast of $285.00. The average price target represents a 8.05% change from the last price of $263.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"202":"$202","223":"$223","244":"$244","265":"$265","286":"$286"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":285,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$285.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":285,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$285.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":285,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$285.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[202,223,244,265,286],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,238.9569230769231,242.79384615384615,246.63076923076923,250.46769230769232,254.30461538461537,258.14153846153846,261.97846153846154,265.81538461538463,269.6523076923077,273.48923076923074,277.32615384615383,281.1630769230769,{"y":285,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,238.9569230769231,242.79384615384615,246.63076923076923,250.46769230769232,254.30461538461537,258.14153846153846,261.97846153846154,265.81538461538463,269.6523076923077,273.48923076923074,277.32615384615383,281.1630769230769,{"y":285,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,238.9569230769231,242.79384615384615,246.63076923076923,250.46769230769232,254.30461538461537,258.14153846153846,261.97846153846154,265.81538461538463,269.6523076923077,273.48923076923074,277.32615384615383,281.1630769230769,{"y":285,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":222.36,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.68,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.52,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.46,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":217.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.05,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220.6,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":241.44,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.72,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.71,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.12,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$285.00

Average Price Target$285.00

Lowest Price Target$285.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Matson

Needham

―

Hold

―

Reiterated

11/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Steris (NYSE: STE) and Jazz Pharmaceuticals (NASDAQ: JAZZ)

Jason Bednar

Piper Sandler

$280→$285

Buy

8.05%

Upside

Reiterated

10/09/25

Piper Sandler Sticks to Its Buy Rating for Steris (STE)

Patrick Wood

Morgan Stanley

$295

Buy

11.84%

Upside

Reiterated

09/09/25

Steris: Strong Global Positioning and Growth Potential Drive Buy Rating

Brett Fishbin

KeyBanc

$288

Buy

9.19%

Upside

Reiterated

08/28/25

KeyBanc Sticks to Its Buy Rating for Steris (STE)Reiterate OW and $288 PT; we remain confident in STE’s FY26 setup.

Michael Polark

Wolfe Research

$265→$270

Buy

2.36%

Upside

Reiterated

08/08/25

Wolfe Research Reaffirms Their Buy Rating on Steris (STE)Wolfe Research analyst Mike Polark raised the price target on STERIS (NYSE: STE) to $270.00 (from $265.00) while maintaining a Outperform rating.

David Windley

Jefferies

$263

Hold

-0.29%

Downside

Reiterated

06/04/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Steris (NYSE: STE) and Apellis Pharmaceuticals (NASDAQ: APLS)

David Turkaly

Citizens JMP

$265→$280

Buy

6.15%

Upside

Reiterated

05/16/25

Steris (STE) Receives a Buy from Citizens JMP

Unknown Analyst

Stephens

Not Ranked

Stephens

$250

Buy

-5.22%

Downside

Reiterated

05/15/25

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Matson

Needham

―

Hold

―

Reiterated

11/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Steris (NYSE: STE) and Jazz Pharmaceuticals (NASDAQ: JAZZ)

Jason Bednar

Piper Sandler

$280→$285

Buy

8.05%

Upside

Reiterated

10/09/25

Piper Sandler Sticks to Its Buy Rating for Steris (STE)

Patrick Wood

Morgan Stanley

$295

Buy

11.84%

Upside

Reiterated

09/09/25

Steris: Strong Global Positioning and Growth Potential Drive Buy Rating

Brett Fishbin

KeyBanc

$288

Buy

9.19%

Upside

Reiterated

08/28/25

KeyBanc Sticks to Its Buy Rating for Steris (STE)Reiterate OW and $288 PT; we remain confident in STE’s FY26 setup.

Michael Polark

Wolfe Research

$265→$270

Buy

2.36%

Upside

Reiterated

08/08/25

David Windley

Jefferies

$263

Hold

-0.29%

Downside

Reiterated

06/04/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Steris (NYSE: STE) and Apellis Pharmaceuticals (NASDAQ: APLS)

David Turkaly

Citizens JMP

$265→$280

Buy

6.15%

Upside

Reiterated

05/16/25

Steris (STE) Receives a Buy from Citizens JMP

Unknown Analyst

Stephens

Not Ranked

Stephens

$250

Buy

-5.22%

Downside

Reiterated

05/15/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Steris

1 Month

xxx

Success Rate

17/33 ratings generated profit

Average Return

+0.30%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 51.52% of your transactions generating a profit, with an average return of +0.30% per trade.

3 Months

xxx

Success Rate

10/15 ratings generated profit

Average Return

+2.26%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.26% per trade.

1 Year

David TurkalyCitizens JMP

Success Rate

28/33 ratings generated profit

Average Return

+9.61%

reiterated a buy rating 7 months ago

Copying David Turkaly's trades and holding each position for 1 Year would result in 84.85% of your transactions generating a profit, with an average return of +9.61% per trade.

2 Years

xxx

Success Rate

30/33 ratings generated profit

Average Return

+19.09%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +19.09% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STE Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, STE has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. STE average Analyst price target in the past 3 months is 285.00.

Each month's total comprises the sum of three months' worth of ratings.

STE Financial Forecast

STE Earnings Forecast

Next quarter’s earnings estimate for STE is $2.53 with a range of $2.47 to $2.61. The previous quarter’s EPS was $2.47. STE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year STE has Performed in-line its overall industry.

STE Sales Forecast

Next quarter’s sales forecast for STE is $1.48B with a range of $1.48B to $1.49B. The previous quarter’s sales results were $1.46B. STE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year STE has Performed in-line its overall industry.

STE Stock Forecast FAQ

What is STE’s average 12-month price target, according to analysts?

Based on analyst ratings, Steris’s 12-month average price target is 285.00.

What is STE’s upside potential, based on the analysts’ average price target?

Steris has 8.05% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is STE a Buy, Sell or Hold?

Steris has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.

What is Steris’s price target?

The average price target for Steris is 285.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $285.00 ,the lowest forecast is $285.00. The average price target represents 8.05% Increase from the current price of $263.77.

What do analysts say about Steris?

Steris’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of STE?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Steris (STE) Stock Forecast & Price Target

STE Analyst Ratings

STE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Steris

STE Analyst Recommendation Trends

STE Financial Forecast

STE Earnings Forecast

STE Sales Forecast

STE Stock Forecast FAQ

Detailed List of Analyst Forecasts